pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Ultragenyx Pharmaceutical Inc. ($RARE) · news · pharmadog
← back to Ultragenyx Pharmaceutical Inc.
News mentioning $RARE
837
stories
May 7, 26
STAT+: FDA to reconsider treatment for rare cancer after its surprise rejection
stat
May 7, 26
STAT+: Next-gen Duchenne drug from Entrada disappoints
stat
May 7, 26
Angelini fortifies neurology portfolio with $4.1B buyout of Catalyst
endpoints
May 7, 26
STAT+: Angelini Pharma buys Catalyst Pharmaceuticals and its rare disease drugs for $4.1B
stat
May 7, 26
Cruise ship hantavirus outbreak worries experts, though they discount pandemic fears
stat
May 6, 26
STAT+: Sanofi asks to pull diabetes drug out of FDA voucher program after political appointee interfered with review
stat
May 6, 26
Disease Assessment and Mutational Testing in Progressive CLL
onclive
May 6, 26
STAT+: Even at a meeting in Rome, FDA shifts are top of mind for gene therapy field
stat
May 5, 26
Vertex earnings get muted investor response
biopharma dive
May 4, 26
With $97M, Latus pursues a different kind of Huntington’s gene therapy
biopharma dive
May 4, 26
UCB to acquire maker of antibody treatments for autoimmune diseases
stat
May 4, 26
What to know about hantavirus, the illness suspected in a cruise ship outbreak
stat
May 4, 26
STAT+: Biotech raises $42 million to run Huntington’s disease trial
stat
May 4, 26
Opinion: STAT+: China’s strict new supply chain regulations could create massive problems for Western biopharma companies
stat
May 2, 26
Federal appeals court blocks mailing of abortion pill mifepristone
stat
May 1, 26
STAT+: Pharmalittle: We’re reading about obesity drugs and a compounding list, an AstraZeneca setback, and more
stat
May 1, 26
STAT+: Her daughter Mila got a bespoke medicine. Now she’s starting a new biotech to make more
stat
May 1, 26
Two biotechs raise a combined $556M in latest spurt of IPOs
biopharma dive
Apr 30, 26
STAT+: Katherine Szarama named acting director of FDA’s vaccines and biologics center
stat
Apr 30, 26
UniQure, in ‘symbolic’ win, to seek UK approval of Huntington’s gene therapy
biopharma dive
Apr 30, 26
Avalyn, in pursuit of better lung drugs, banks $300M in an IPO
biopharma dive
Apr 29, 26
STAT+: Supreme Court justices appear to signal ‘skinny labeling’ can survive
stat
Apr 29, 26
Chiesi to buy KalVista in $1.9B deal for rare disease drug
biopharma dive
Apr 29, 26
STAT+: A patent win for Pfizer and BridgeBio
stat
Apr 29, 26
STAT+: Pharmalittle: We’re reading about the FDA speeding up trials, a Supreme Court hearing on ‘skinny labels,’ and more
stat
Apr 29, 26
Opinion: The medical school nutrition blues
stat
Apr 29, 26
Opinion: STAT+: Did Kennedy just stack the deck on FDA oversight of peptides?
stat
Apr 29, 26
In first meeting, federal autism committee focuses on ‘profound autism’
stat
Apr 28, 26
STAT+: Health system CEOs get off easy at Congressional hearing on affordability
stat
Apr 28, 26
STAT+: AIDS group sues Trump administration over undisclosed agreement with Gilead
stat
← prev
page 27 of 28
next →
